K Number
K980731
Date Cleared
1998-05-22

(86 days)

Product Code
Regulation Number
862.1345
Panel
CH
Reference & Predicate Devices
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The Accu-Chek Comfort Curve Test Strips are to be used with the Accu-Chek® Advantage® and Accu-Chek® Complete™ Monitors. The Accu-Chek Advantage and Accu-Chek Complete systems are designed for testing glucose in whole blood by persons with diabetes or by health care professionals in the home or in health care facilities.

Professionals may use the test strips to test capillary, venous, arterial and neonate (including cord) blood samples; lay use is limited to capillary blood testing.

Device Description

The Accu-Chek Comfort Curve Test Strips are to be used with the Accu-Chek® Advantage® and Accu-Chek® Complete™ Monitors. The Accu-Chek Comfort Curve test strips are designed for convenient, confident, and accurate testing of blood glucose in whole blood samples.

AI/ML Overview

The provided text is a 510(k) summary for the Accu-Chek® Comfort Curve™ Test Strip. It describes the device, its intended use, and its substantial equivalence to a predicate device, but it does not contain details about specific acceptance criteria or a study proving the device meets those criteria.

Therefore, I cannot provide the requested information based on the input text. The document focuses on regulatory approval and comparison to a predicate device rather than performance study results.

§ 862.1345 Glucose test system.

(a)
Identification. A glucose test system is a device intended to measure glucose quantitatively in blood and other body fluids. Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma.(b)
Classification. Class II (special controls). The device, when it is solely intended for use as a drink to test glucose tolerance, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.